These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288. Knight YE, Edvinsson L, Goadsby PJ. Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470 [Abstract] [Full Text] [Related]
7. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine. Wang X, Fang Y, Liang J, Yin Z, Miao J, Luo N. Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348 [Abstract] [Full Text] [Related]
8. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Bellamy JL, Cady RK, Durham PL. Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148 [Abstract] [Full Text] [Related]
15. Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine. Piper RD, Edvinsson L, Ekman R, Lambert GA. Cephalalgia; 1993 Jun; 13(3):180-3; discussion 149. PubMed ID: 8395344 [Abstract] [Full Text] [Related]
16. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Levy D, Burstein R, Strassman AM. Ann Neurol; 2005 Nov; 58(5):698-705. PubMed ID: 16240341 [Abstract] [Full Text] [Related]
17. Monitoring cortical hemodynamic changes after sumatriptan injection during migraine attack by near-infrared spectroscopy. Watanabe Y, Tanaka H, Dan I, Sakurai K, Kimoto K, Takashima R, Hirata K. Neurosci Res; 2011 Jan; 69(1):60-6. PubMed ID: 20875464 [Abstract] [Full Text] [Related]
18. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Villalón CM, Centurión D, Valdivia LF, De Vries P, Saxena PR. Proc West Pharmacol Soc; 2002 Jan; 45():199-210. PubMed ID: 12434581 [Abstract] [Full Text] [Related]